Previous 10 | Next 10 |
Revenue increase of 73% from Q4 22 and 8% from Q1 22 Reduction of net loss by $0.2 million or 19% versus Q1 22 Reduction of EBITDAS loss by $0.2 million or 23% versus Q1 22 Reduction in net loss per share of 44% versus Q1 22 BOULDER, CO / ACCESSWIRE / August 11, 2022 / ...
Gainers: Applied DNA Sciences ( APDN ) +93% . Alnylam Pharmaceuticals ALNY +55% . Poseida Therapeutics PSTX +47% . NeuroOne Medical Technologies ( NMTC ) +31% . Sonoma Pharmaceuticals ( SNOA ) +21% . Losers: BridgeBio Pharma B...
WOODSTOCK, GA / ACCESSWIRE / August 2, 2022 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and...
Revenues increased 7% in Q4 2022 compared to Q4 2021 Net loss per share improved quarter over quarter and year over year Strong balance sheet with $7.4 million of cash WOODSTOCK, GA / ACCESSWIRE / July 13, 2022 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA),a global healthcare...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips BYND Cannasoft Enterprises (NASDAQ: BCAN ) stock is at the top of our gainers today. Sportsman’s Warehouse (NASDAQ: SPWH ) leads our losers this morning. Recent earnings continue to be behind stock m...
Woodstock, Georgia-based Sonoma Pharmaceuticals (NASDAQ:SNOA) and its partner, the MicroSafe Group DMCC announced on Wednesday that Nanocyn hospital grade disinfectant has been included in a list of COVID-19 disinfectants maintained by the U.S. Environmental Protection Agency (EPA). Sonoma (S...
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions a...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sonoma Pharmaceuticals (NASDAQ: SNOA ) stock is getting a boost on Tuesday after the company revealed positive news from the U.S. Environmental Protection Agency (EPA). Source: Maridav/ShutterStock.com The big...
Gainers: Sonoma Pharmaceuticals (SNOA) +29%. Blue Water Vaccines (BWV) +32%. XORTX Therapeutics (XRTX) +27%. Eqonex (EQOS) +21%. TETRA Technologies (TTI) +20%. Enovix (ENVX) +18%. JAKKS Pacific (JAKK) +18%. Blue Apron Holdings (APRN) +17%. Borr Drilling (BORR) +16%. Western Digital Corp...
Gainers: Sonoma Pharmaceuticals (SNOA) +42%. XORTX Therapeutics (XRTX) +18%. Retractable Technologies (RVP) +14%. Catalent (CTLT) +12%. Field Trip Health (FTRP) +5%. Losers: Spero Therapeutics (SPRO) -61%. Semler Scientific (SMLR) -23%. Galmed Pharmaceu...
News, Short Squeeze, Breakout and More Instantly...
Sonoma Pharmaceuticals Inc. Company Name:
SNOA Stock Symbol:
NASDAQ Market:
Sonoma Pharmaceuticals Inc. Website:
BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasa...
BOULDER, CO / ACCESSWIRE / April 4, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal ...
BOULDER, CO / ACCESSWIRE / March 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal...